IL147079A0 - Pharmaceutical composition containing sibutramine and orlistat - Google Patents
Pharmaceutical composition containing sibutramine and orlistatInfo
- Publication number
- IL147079A0 IL147079A0 IL14707900A IL14707900A IL147079A0 IL 147079 A0 IL147079 A0 IL 147079A0 IL 14707900 A IL14707900 A IL 14707900A IL 14707900 A IL14707900 A IL 14707900A IL 147079 A0 IL147079 A0 IL 147079A0
- Authority
- IL
- Israel
- Prior art keywords
- orlistat
- pharmaceutical composition
- composition containing
- containing sibutramine
- sibutramine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9914744.9A GB9914744D0 (en) | 1999-06-24 | 1999-06-24 | Therapeutic agents |
| PCT/EP2000/005542 WO2001000205A1 (en) | 1999-06-24 | 2000-06-16 | Pharmaceutical composition containing sibutramine and orlistat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL147079A0 true IL147079A0 (en) | 2002-08-14 |
Family
ID=10855955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14707900A IL147079A0 (en) | 1999-06-24 | 2000-06-16 | Pharmaceutical composition containing sibutramine and orlistat |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1187606A1 (bg) |
| JP (1) | JP2003503349A (bg) |
| KR (1) | KR20020015357A (bg) |
| CN (1) | CN1358092A (bg) |
| AU (1) | AU5533200A (bg) |
| BG (1) | BG106180A (bg) |
| BR (1) | BR0011880A (bg) |
| CA (1) | CA2375972A1 (bg) |
| CZ (1) | CZ20014613A3 (bg) |
| GB (1) | GB9914744D0 (bg) |
| HK (1) | HK1049278A1 (bg) |
| HU (1) | HUP0201878A3 (bg) |
| IL (1) | IL147079A0 (bg) |
| MX (1) | MXPA01012936A (bg) |
| NO (1) | NO20016224L (bg) |
| PL (1) | PL352402A1 (bg) |
| RU (1) | RU2229289C2 (bg) |
| SK (1) | SK18242001A3 (bg) |
| TR (1) | TR200103699T2 (bg) |
| WO (1) | WO2001000205A1 (bg) |
| ZA (1) | ZA200109989B (bg) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696495B2 (en) * | 1998-12-02 | 2004-02-24 | Snowden Pharmaceuticals, Llc | Treatment of disorders secondary to organic impairments |
| US20040214804A1 (en) * | 2003-04-25 | 2004-10-28 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and an anti-obesity agent |
| BRPI0517434A (pt) | 2004-10-25 | 2008-10-07 | Solvay Pharm Gmbh | composições farmacêuticas compreendendo antagonistas do receptor canabinóide cb1 e abridores de canal de potássio para o tratamento de diabetes mellitus do tipo i, obesidade e estados relacionados |
| US8604244B2 (en) | 2010-07-02 | 2013-12-10 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
| CA2663254C (en) | 2006-09-15 | 2016-04-19 | Reviva Pharmaceuticals, Inc. | Synthesis, methods of using, and compositions of cycloalkylmethylamines |
| KR20080046601A (ko) * | 2006-11-22 | 2008-05-27 | 에스케이케미칼주식회사 | 보관안정성이 우수한 시부트라민 함유 포접복합체 |
| CN101890017A (zh) * | 2009-05-22 | 2010-11-24 | 北京奥萨医药研究中心有限公司 | 含有西布曲明和他汀类降脂药物的药物组合物及其用途 |
| MX336980B (es) * | 2010-12-21 | 2016-02-09 | Senosiain S A De C V Lab | Combinacion y composicion para el tratamiento de obesidad. |
| RU2642074C2 (ru) | 2011-12-30 | 2018-01-24 | Ревива Фармасьютикалс, Инк. | Композиции, синтез и способы применения производных фенилциклоалкилметиламина |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9727131D0 (en) * | 1997-12-24 | 1998-02-25 | Knoll Ag | Therapeutic agents |
-
1999
- 1999-06-24 GB GBGB9914744.9A patent/GB9914744D0/en not_active Ceased
-
2000
- 2000-06-16 CA CA002375972A patent/CA2375972A1/en not_active Abandoned
- 2000-06-16 CZ CZ20014613A patent/CZ20014613A3/cs unknown
- 2000-06-16 KR KR1020017016575A patent/KR20020015357A/ko not_active Application Discontinuation
- 2000-06-16 EP EP00940379A patent/EP1187606A1/en not_active Withdrawn
- 2000-06-16 MX MXPA01012936A patent/MXPA01012936A/es unknown
- 2000-06-16 BR BR0011880-0A patent/BR0011880A/pt not_active IP Right Cessation
- 2000-06-16 AU AU55332/00A patent/AU5533200A/en not_active Abandoned
- 2000-06-16 HU HU0201878A patent/HUP0201878A3/hu unknown
- 2000-06-16 JP JP2001505914A patent/JP2003503349A/ja active Pending
- 2000-06-16 SK SK1824-2001A patent/SK18242001A3/sk unknown
- 2000-06-16 CN CN00809372A patent/CN1358092A/zh active Pending
- 2000-06-16 IL IL14707900A patent/IL147079A0/xx unknown
- 2000-06-16 PL PL00352402A patent/PL352402A1/xx not_active Application Discontinuation
- 2000-06-16 WO PCT/EP2000/005542 patent/WO2001000205A1/en not_active Application Discontinuation
- 2000-06-16 TR TR2001/03699T patent/TR200103699T2/xx unknown
- 2000-06-16 RU RU2002102076/14A patent/RU2229289C2/ru not_active IP Right Cessation
-
2001
- 2001-12-04 BG BG106180A patent/BG106180A/bg unknown
- 2001-12-05 ZA ZA200109989A patent/ZA200109989B/xx unknown
- 2001-12-19 NO NO20016224A patent/NO20016224L/no not_active Application Discontinuation
-
2003
- 2003-01-09 HK HK03100246.9A patent/HK1049278A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9914744D0 (en) | 1999-08-25 |
| SK18242001A3 (sk) | 2003-02-04 |
| BG106180A (bg) | 2002-08-30 |
| TR200103699T2 (tr) | 2002-04-22 |
| HK1049278A1 (zh) | 2003-05-09 |
| CA2375972A1 (en) | 2001-01-04 |
| MXPA01012936A (es) | 2004-04-21 |
| EP1187606A1 (en) | 2002-03-20 |
| HUP0201878A2 (hu) | 2003-08-28 |
| WO2001000205A1 (en) | 2001-01-04 |
| HUP0201878A3 (en) | 2005-04-28 |
| AU5533200A (en) | 2001-01-31 |
| NO20016224D0 (no) | 2001-12-19 |
| CZ20014613A3 (cs) | 2003-04-16 |
| CN1358092A (zh) | 2002-07-10 |
| RU2229289C2 (ru) | 2004-05-27 |
| KR20020015357A (ko) | 2002-02-27 |
| PL352402A1 (en) | 2003-08-25 |
| BR0011880A (pt) | 2002-03-19 |
| ZA200109989B (en) | 2003-02-26 |
| JP2003503349A (ja) | 2003-01-28 |
| NO20016224L (no) | 2002-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL144977A0 (en) | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| IL150224A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
| HRP20060251B1 (hr) | Supstituirani oksazolidinoni i njihova uporaba | |
| IL150223A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
| HUP0200548A2 (hu) | Gyógyszerészeti készítmények és alkalmazásuk | |
| HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0004398A3 (en) | Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same | |
| HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| IL133097A0 (en) | Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof | |
| IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
| HUP0203896A3 (en) | Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof | |
| HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
| HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
| HUP0101733A3 (en) | Pharmaceutical compositions containing sulfonyl-dipeptides and their use | |
| PL352402A1 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
| EG22491A (en) | Rest-breaking composition and use thereof | |
| HUP0103006A3 (en) | Substituted betha-diketones, pharmaceutical compositions containing them and their use | |
| SI1039900T1 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
| GB9911606D0 (en) | Composition and use | |
| ZA9811105B (en) | Cosmetic and pharmaceutical composition | |
| GB9929581D0 (en) | Comjpositions and their use | |
| HUP9903500A3 (en) | Thiophene-, furane- and pyrrolesulfonamides, their use and pharmaceutical compositions containing them |